Skip to content

Cevimeline

Evoxac (cevimeline) is a small molecule pharmaceutical. Cevimeline was first approved as Evoxac on 2000-01-11. It is used to treat xerostomia in the USA. It is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M3.
Trade Name Evoxac
Common Name Cevimeline
Indication xerostomia
Drug Class Cholinergic agonists (arecoline derivatives used in treatment of Alzheimer disease)
Cevimeline
Get full access now